|
|||||
|
|
NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized,double‐blind,placebo‐controlled study |
|
| Authors: | Christopher F. O'Brien MD Roland Jimenez Robert A. Hauser MD MBA Stewart A. Factor DO Joshua Burke Daniel Mandri MD Julio C. Castro‐Gayol MD |
| Affiliation: | 1. Neurocrine Biosciences, San Diego, California, USA;2. University of South Florida, Tampa, Florida, USA;3. Emory University, Atlanta, Georgia, USA;4. Biscayne Bay Institute, Miami, Florida, USA;5. Research in Miami, Miami, Florida, USA |
| Abstract: | |
| Keywords: | tardive dyskinesia vesicular monoamine transporter (VMAT2) antipsychotic drugs randomized controlled trial |